These included male sex, age under 45 years, BMI exceeding 25, external thyroid invasion, tumor diameter greater than 1 cm, presence of vascular cancer thrombus, multifocal tumors, BRAF V-600E gene mutation, and ICLNM [9, 16–21]. This evidence concerns the gene BRAF and vascular cancer.